Skip to content

COLCHICINE OPOCALCIUM 1 mg

DRUG4 trials

Sponsors

Assistance Publique Hopitaux De Paris, Clinique Saint Augustin

Conditions

AtherosclerosisAtrial fibrillationCardiac DiseaseCerebral InfarctionCoronary SyndromeFamilial Mediterranean Fever (FMF)IschemicMyocardial Infarction

Phase 3

Randomized controlled trial in patients on long-term colchicine with colchicine-resistant familial Mediterranean fever (FMF) to evaluate the efficacy of on-demand Anakinra treatment for painful attacks in patients who refuse continuous daily therapy (KIN-ATTACK-FMF).
RecruitingCTIS2023-506721-11-00
Assistance Publique Hopitaux De ParisFamilial Mediterranean Fever (FMF)
Start: 2024-06-04Target: 50Updated: 2024-10-30
RIISC THETIS Evaluation of low dose colchicine in prevention of ischemic stroke in patients with stroke due to atherosclerosis. Reducing inflammation in ischemic stroke with colchicine (riisc),
RecruitingCTIS2024-513669-38-00
Assistance Publique Hopitaux De ParisAtherosclerosis, Cardiac Disease, Cerebral Infarction +5
Start: 2023-05-17Target: 1400Updated: 2025-11-07
ARGO Colchicine versus Placebo in Acute Myocarditis Patients to Reduce Late Gadolinium Enhancement Mass on Cardiac Magnetic Resonance and the risk of Clinical Outcomes: The ARGO trial
Not yet recruitingCTIS2024-514610-13-00
Assistance Publique Hopitaux De Parispatients suffering from acute myocarditis confirmed on Cardiac magnetic resonance imaging.
Target: 300Updated: 2026-01-14
Multicenter and randomised study on atrial fibrillation prevention after cardiac surgery with a 3-way comparison between standard of care, posterior pericardiotomy and a treatment bundle (colchicine, amiodarone and posterior pericardiotomy) (PREV-AF)
Not yet recruitingCTIS2025-523209-14-00
Clinique Saint AugustinAtrial fibrillation
Target: 636Updated: 2026-10-02